NIVF · NewGenIvf Group Ltd
$1.31
-0.01 (-0.76%)
At close · Jul 20
Market Cap
$4.48M
Shares
3.42M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$4.73M
-13%
FY2025
Net Income
$9.88M
+1983.1%
FY2025
Gross Margin
20.22%
-13.4pp
FY2025
Operating Margin
-226.95%
-205.6pp
FY2025
Diluted EPS
$9.12
+101.6%
FY2025
Operating Cash Flow
-$10.93M
-32.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| $4.73M | $5.43M | $5.14M | |
| $3.77M | $3.61M | $3.45M | |
| $955.85K | $1.83M | $1.68M | |
| 20.22% | 33.62% | 32.74% | |
| $1.19M | $206.31K | $18.03K | |
| $10.49M | $2.78M | $1.26M | |
| $188.11K | $19.5K | $31.17K | |
| $11.68M | $2.99M | $1.64M | |
| -$10.73M | -$1.16M | $42.24K | |
| -226.95% | -21.36% | 0.82% | |
| -$10.54M | -$1.14M | $73.42K | |
| $765.18K | $765.18K | — | |
| $2251 | $6953 | $518 | |
| $20.46M | $199.69K | $66.18K | |
| $9.73M | -$960.81K | $108.42K | |
| -$486.71K | -$486.71K | $208.14K | |
| $9.88M | -$524.64K | $130.19K | |
| 209.02% | -9.66% | 2.53% | |
| -$150.69K | $50.54K | -$21.78K | |
| $9.51M | -$441.57K | $113.34K | |
| USD/shares | $644.19 | -$1,188.00 | $1,620.00 |
| USD/shares | $9.12 | -$576.00 | $1,620.00 |
| shares | 15.34K | 397.8978 | 68.3483 |
| shares | 1.08M | 825.9144 | 68.3483 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Kyrgyzstan | $2,312,348 | $2,656,596 | $3,123,593 | $5,060,973 | $3,110,483 |
| Thailand | $1,691,862 | $2,175,253 | $1,356,903 | $505,609 | $693,900 |
| Cambodia | $635,188 | $601,526 | $621,619 | $377,608 | $313,737 |
| Hong Kong SAR China | $209,630 | $3,081 | $34,038 | — | — |
| United States | $45,480 | — | — | — | — |
| China HKSAR | $41,555 | — | — | — | — |
| China | — | $8,370 | — | — | — |
| HKSAR | — | — | $34,038 | — | — |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| IVF Treatment Service | $3,905,863 | $5,433,375 | $4,021,696 | $2,819,163 | $3,199,683 |
| Fertility Referral Services | $820,570 | — | — | — | — |
| Surrogacy Ancillary Caring and Other Services | — | — | $1,114,457 | $3,125,027 | $918,437 |